Canada Markets closed

Pfizer Inc. (PFE)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
43.83-0.25 (-0.57%)
At close: 04:03PM EDT
43.92 +0.09 (+0.21%)
After hours: 04:41PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close44.08
Open43.81
Bid44.10 x 1200
Ask44.11 x 1400
Day's Range43.67 - 44.33
52 Week Range40.94 - 61.71
Volume15,235,719
Avg. Volume17,705,993
Market Cap246.012B
Beta (5Y Monthly)0.68
PE Ratio (TTM)25.68
EPS (TTM)1.71
Earnings DateMay 02, 2022 - May 06, 2022
Forward Dividend & Yield1.60 (3.17%)
Ex-Dividend DateJul 28, 2022
1y Target Est58.49
  • Zacks

    Valneva (VALN) Stock Down 66% in the Past 6 Months: Here's Why

    Valneva's (VALN) COVID-19 vaccine looks promising, but the European Commission's revised advance purchase agreement jeopardizes its COVID-19 vaccine program.

  • Baystreet

    An Ideal ETF for Buy-and-Hold Investors

    If you're looking for an investment that you can buy and hold for years, you'll probably want both some ...

  • Reuters

    UPDATE 1-Pfizer/BioNTech seek FDA nod for new COVID boosters for children

    Pfizer Inc and its German partner BioNTech on Monday sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years. The application comes just days after Moderna also applied for FDA authorization of its own Omicron-targeting shot in adolescents aged 12 to 17 years and children aged six to 11. The applications represent a step towards getting children vaccinated by a so-called bivalent vaccine, which targets both the original strain of the virus and the circulating BA.4 and BA.5 subvariants of Omicron.